ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
66.863,59
-0,32%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Fennec Pharmaceuticals Inc (FENC)

  7. Fennec Pharmaceuticals Inc (FENC) News

FENC

Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FENC
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202423h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
14/05/202412h03GlobeNewswire Inc.Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
13/05/202422h42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FENCFennec Pharmaceuticals Inc
08/05/202400h15GlobeNewswire Inc.Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
21/03/202411h00GlobeNewswire Inc.Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
19/03/202411h01GlobeNewswire Inc.Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
18/03/202408h00PR Newswire (US)Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
18/03/202402h00GlobeNewswire Inc.Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
06/03/202422h07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FENCFennec Pharmaceuticals Inc
29/02/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FENCFennec Pharmaceuticals Inc
29/02/202413h04GlobeNewswire Inc.Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsNASDAQ:FENCFennec Pharmaceuticals Inc
14/02/202416h47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FENCFennec Pharmaceuticals Inc
01/02/202411h55GlobeNewswire Inc.FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving CisplatinNASDAQ:FENCFennec Pharmaceuticals Inc
05/01/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
05/01/202422h45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
04/01/202422h42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
29/12/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
28/12/202321h51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
18/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FENCFennec Pharmaceuticals Inc
05/12/202311h55GlobeNewswire Inc.Fennec Announces Incremental $5 Million Investment from PetrichorNASDAQ:FENCFennec Pharmaceuticals Inc
16/11/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202322h56Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202322h52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202322h50GlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202322h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202300h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
06/11/202311h59GlobeNewswire Inc.Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
03/11/202322h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
30/10/202311h45GlobeNewswire Inc.Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:FENCFennec Pharmaceuticals Inc
07/09/202311h59GlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:FENC

Kürzlich von Ihnen besucht

AMEX
AEN
LSE
EMR
Empresaria
COIN
NBSBTC
New BitShares
KOSPI
002600
Choheung
USOTC
STJPF
St James Cap (PK)
BIT
F15543
Vontobel Financial Produ...
NYSE
NGL.PRB
NGL Energy Partners LP
COIN
METAVUST
METAVPAD.com
BSTP
GALAEUR
Gala
LSE
VOX
Vox Valor Capital
COIN
CMCTOGBP
CyberMovieChain
ASX
TMZOB
Thomson Resources
BIBX
BATBTC
Basic Attention Token
COIN
NIOXUSD
Autonio
BOV
ELETF335
ELETF335 Ex:33,1
EU
S975S
S975S
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten